Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
D000569:Americas; D015982:Bias; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D017135:Desogestrel; D019049:Developed Countries; D004194:Disease; D004617:Embolism; D005060:Europe; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006077:Government Agencies; D009656:North America; D009938:Organizations; D012106:Research; D012107:Research Design; D013923:Thromboembolism; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration; D014492:United States Public Health Service; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D017135:Desogestrel
Americas; Bias; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Critique; Desogestrel; Developed Countries; Diseases; Embolism; Error Sources; Europe; Family Planning; Gestodene; Government Agencies; Measurement; North America; Northern America; Northern Europe; Oral Contraceptives; Oral Contraceptives, Combined; Organizations; Research Methodology; Thromboembolism; United Kingdom; United States; Usfda; Usphs; Vascular Diseases